Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SE vs GSK✓SelectedUSD · GSKSE vs GSK performance historyLatest closeAs of-4.95%11/16
Stock and ETF performance explorer

SE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-77.2%
GSK return
+47.4%
Excess return
-124.6%
Maximum drawdown
-88.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.9%-0.1%-4.9%-4.9%
7D-8.1%-1.3%-6.8%-7.8%
30D-23.6%+2.7%-26.3%-24.3%
3M-41.3%+2.7%-44.0%-41.8%
6M-18.8%+3.3%-22.1%-20.1%
YTD-43.9%+6.5%-50.3%-45.4%
1Y-49.1%+10.7%-59.8%-51.2%
3Y+89.0%+64.4%+24.6%+47.3%
All-77.2%+47.4%-124.6%-80.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling